Source: mpo-mag

BioDerm: Argentum Medical Sold to BioDerm

Shore Capital Partners has sold Argentum Medical, a provider of infection prevention solutions and wound care products, to BioDerm, a portfolio company of Mountaingate Capital. Financial terms of the deal were not disclosed.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Gaet Tyranski's photo - President & CEO of BioDerm

President & CEO

Gaet Tyranski

CEO Approval Rating

90/100

Read more